RWM
JAZZ icon

Ritholtz Wealth Management’s Jazz Pharmaceuticals JAZZ Stock Holding History

Ritholtz Wealth Management’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.73M Sell
19,728
-1,886
-9% -$330K 0.06% 227
2025
Q4 		$3.67M Buy
21,614
+1,144
+6% +$175K 0.07% 211
2025
Q3 		$2.7M Buy
20,470
+3,937
+24% +$472K 0.05% 252
2025
Q2 		$1.75M Buy
16,533
+1,237
+8% +$134K 0.04% 327
2025
Q1 		$1.9M Buy
+15,296
New +$2M 0.06% 259

Other funds holding JAZZ

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Ritholtz Wealth Management's JAZZ Position: Q1 2026 in Review

Ritholtz Wealth Management reduced its Jazz Pharmaceuticals (JAZZ) stake by 8.7% in Q1 2026, selling an estimated $330K and leaving 19,728 shares worth $3.73M. The position accounts for 0.06% of the portfolio, ranked #227.

Ritholtz Wealth Management first reported a position in JAZZ in Q1 2025 and has held it in 5 quarters since. 570 funds tracked by Wall St. Rank hold JAZZ as of Q1 2026.

  • Ritholtz Wealth Management held 19,728 shares of Jazz Pharmaceuticals worth $3.73M as of Q1 2026.
  • Ritholtz Wealth Management sold 1,886 Jazz Pharmaceuticals shares in Q1 2026, an estimated $330K.
  • Jazz Pharmaceuticals made up 0.06% of Ritholtz Wealth Management's portfolio in Q1 2026, its #227 holding.
  • Ritholtz Wealth Management first reported a position in Jazz Pharmaceuticals in Q1 2025 and has held it in 5 quarters since.
  • 570 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2026.

Based on Ritholtz Wealth Management's 13F filing for Q1 2026, filed 20 Apr 2026.